Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Virax Biolabs Group Limited VRAX
$0.36
+$0.01 (2.26%)
На 17:51, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
5596956.00000000
-
week52high
29.00
-
week52low
0.34
-
Revenue
0
-
P/E TTM
-2
-
Beta
0.00000000
-
EPS
-0.21000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 09:16
Описание компании
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference
PRNewsWire
06 февр 2023 г. в 16:05
LONDON , Feb. 6, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Dr. Tomasz George, Chief Scientific Officer of Virax, and Cameron Shaw, Chief Operations Officer at Virax, will be presenting at the BIO CEO & Investor Conference on Tuesday, February 7, 2023. The presentation will highlight the recent Company developments, anticipated milestones and ongoing clinical and business developments.
7 Top Penny Stocks To Watch With Big News This Week
PennyStocks
04 янв 2023 г. в 09:14
Hot penny stocks to watch with news this week. The post 7 Top Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Biggest Beginner Penny Stocks Trading Mistakes? 3 to Know
PennyStocks
04 ноя 2022 г. в 06:00
Are you making these beginner penny stocks trading mistakes? The post Biggest Beginner Penny Stocks Trading Mistakes?
Why Is Virax (VRAX) Stock Up 40% Today?
InvestorPlace
03 ноя 2022 г. в 10:51
Small-cap business Virax Biolabs (NASDAQ: VRAX ) isn't often in the headlines, but today is a special day for the company. Reportedly, Virax's new rapid testing kit is a triple-threat.
Hot Penny Stocks to Buy? 3 to Watch as September Ends
PennyStocks
21 сент 2022 г. в 06:00
Which penny stocks are on your watchlist today? The post Hot Penny Stocks to Buy?